Ixico Plc Ord New (PHYOF) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good afternoon and welcome to the Ixaco PLC investor presentation. Throughout today's recorded presentation, attendees will be in listen-only mode. Questions are encouraged and can be submitted via the Q&A tab situated on the right-hand side of your screen. Before we begin, I'd just like to submit the following poll, which I kindly ask you to submit your responses to. I'd now like to hand over to the executive management team. Bram, good afternoon. Good afternoon and thank you for this introduction. I don't think Bram's needs introduction, CFO and Chief Operating Officer of the company, and then myself, Bram Gordon C, Chief Executive Officer. We're reporting out our first half of the financial year 26 results. which we are very proud of. I hope you will agree with that as we go through this presentation. And as usual, Grant and I will both present the numbers, some elements of our strategy, of course, as well. Also following a recent capital raise, which I'm sure some of you might be interested in hearing what exactly we are doing with these proceeds and how this is going to change. We believe also the trajectory of this company in the near and somewhat more distant future. So with that in mind, For many of you, probably the company doesn't require an introduction, but just to sort of level set, we consider ourselves the leading imaging CRO focused exclusively on neurology. And also with this recent capital raise, you will see that neurology is still very much going to remain our core market because we also know that we are operating on fertile ground when we talk about neurology. One thing that I do want to call out besides sort of the usual numbers that you see here to the right hand side in terms of the size of our company, our customer base, and obviously more im...